Clinical trial
Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet…
NCT00051129 · Alcon Research, Industry · Completed
Key facts
| NCT number | NCT00051129 |
|---|---|
| Title | Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD) |
| Official title | An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal Choroidal Neovascularization Due to Exudative Age-Related Macular Degeneration. |
| Lead sponsor | Alcon Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Macular Degeneration, Maculopathy, Age-Related, Age-Related Maculopathies, Age-Related Maculopathy, Maculopathies |
| Intervention type | Drug, Other |
| Interventions | Anecortave Acetate 15 mg sterile suspension, Anecortave Acetate Vehicle |
| Enrollment | 291 |
| Start date | Jan 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jan 7, 2003 |
| Last update posted | Nov 28, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: